St. Jude's Children's Research Hospital (Children Cancers)

William Evans. Dr. William E. Evans has served as St. Jude Children’s Research Hospital’s fifth director and CEO since 2004. From 1986 to 2002, he chaired the St. Jude Department of Pharmaceutical Sciences, and from 2002 to 2004 served as the hospital’s scientific director and executive vice president. He also currently holds the St. Jude Professorship and Endowed chair at the University… See full bio.

The nonprofit has not added any comments yet. If you are a representative of this nonprofit and would like to leave a comment, please email us at feedback@myphilanthropedia.org with your request.

Story: When late entertainer Danny Thomas opened the doors to St. Jude Children’s Research Hospital in 1962, he was not just changing the lives of children who would walk through its doors—he was changing lives across the world. When St. Jude completed its $1 billion, five-year expansion in 2005, it bolstered the hospital's efforts to find cures for the catastrophic diseases of childhood. The growth more than doubled the size of the hospital’s original campus. The expansion included the Children's GMP, LLC—the nation's only pediatric research center on-site facility for production of highly specialized treatments and vaccines—an expanded Department of Immunology and more. Now with the addition of the Chili’s Care Center, a larger, rejuvenated Kay Kafe cafeteria for employees and patients, and renovations to the medicine room and rehabilitation areas, the hospital is more poised than ever to advance cures, and means of prevention, for pediatric catastrophic diseases through research and treatment.

Evidence of Impact Summary:

St. Jude's Children's Research Hospital has been focusing on children suffering from cancer for years and has become a well-known group among the public.
See expert comments.

Organization Strengths Summary:

The major strengths of this hospital are its caring and dedicated staff and its effective use of marketing techniques, according to experts.
See expert comments.

Areas for Improvement Summary:

The main area of improvement for St. Jude's Children's Research Hospital is in its capacity--it could expand to provide services to more children.
See expert comments.

Select the boxes to display the results according to expert type.

Show:

Select the boxes to display the results according to expert type.

Show:

Select the boxes to display the results according to expert type.

Show:

Dr. William E. Evans has served as St. Jude Children’s Research Hospital’s fifth director and CEO since 2004. From 1986 to 2002, he chaired the St. Jude Department of Pharmaceutical Sciences, and from 2002 to 2004 served as the hospital’s scientific director and executive vice president. He also currently holds the St. Jude Professorship and Endowed chair at the University of Tennessee Colleges of Medicine and Pharmacy. Evans received his doctoral degree (Pharm.D) from the University of Tennessee (1975), and spent a sabbatical year at the University of Basel (1987-88) studying pharmacogenomics. He received an honorary doctor of science degree (honoris causa) from Ohio State University in 2008. Evans’ research is on the pharmacodynamics and pharmacogenomics of anticancer agents in children, exploring genetic and biochemical mechanisms underlying differences in drug effects among children. He has received three consecutive NCI MERIT Awards from the National Institutes of Health for his research of antileukemic agents in children. He has received several national and international awards for his research, including the Leon Goldberg Award in 1991 and the Rawls Palmer Progress in Medicine Award in 2006 from the American Society for Clinical Pharmacology and Therapeutics, the Therapeutic Frontiers Lecture Award in 1989 and the Russell Miller Research Award in 1992 from the American College of Clinical Pharmacy (ACCP), the Volwiler Research Award in 1994 from the American Association of Colleges of Pharmacy, the Research Achievement Award in 1996 and the Tyler Prize in 2002 from the American Pharmacists Association (APhA). He is an elected fellow of the American Association for the Advancement of Science (AAAS), the American Association of Pharmaceutical Scientists and the ACCP. He has also held elected offices as president of the ACCP (1982), president of APhA’s Academy of Pharmaceutical Research and Science (1988), and chair of AAAS’s Pharmaceutical Sciences Section (2009-10). He was elected to the Institute of Medicine of the U.S. National Academy of Sciences in 2002. With citations of his publications ranking among the top one percentile of scientists worldwide in his field, Evans is recognized by ISI as a “Highly Cited Scientist.” He has authored over 300 scientific publications and book chapters. Under his leadership, St. Jude has expanded its research focus to include Chemical Biology and Therapeutics, Epidemiology and Cancer Control, and has exploited new technologies to further elucidate the genomic basis of childhood cancers and to develop individualized approaches to cancer treatment through translation of pharmacogenomic discoveries into innovative treatment protocols of childhood cancers. During his tenure as CEO, St. Jude has been consistently ranked among the top ten Best Places to Work in Academia by The Scientist Magazine, including their #1 ranking in 2006; the #1 Children’s Cancer Hospital by Parent Magazine in 2009; the #1 children’s cancer hospital by U.S. News & World Report in 2010; and in 2011, on FORTUNE magazine’s 100 Best Companies to Work For list. In 2008, St. Jude was designated as the first and only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. And in 2010, the hospital launched the Pediatric Cancer Genome Project in collaboration with Washington University School of Medicine in St. Louis.

The nonprofit has not added any comments yet. If you are a representative of this nonprofit and would like to leave a comment, please email us at feedback@myphilanthropedia.org with your request.